Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yuki Mawatari-Furukawa"'
Autor:
Tomoki Yamano, Shuji Kubo, Miki Fukumoto, Aya Yano, Yuki Mawatari-Furukawa, Haruki Okamura, Naohiro Tomita
Publikováno v:
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
Cancer vaccine application is limited to specific cancer types because few cancer-associated antigens are known to induce tumor rejection. Accordingly, we assessed the utility of Ad881, an oncolytic adenovirus in which viral replication was strictly
Externí odkaz:
https://doaj.org/article/9f731ec6f20c44d3a512d66e20eb4076
Autor:
Shuji Kubo, Aya Yano, Haruki Okamura, Naohiro Tomita, Miki Fukumoto, Tomoki Yamano, Yuki Mawatari-Furukawa
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
Cancer vaccine application is limited to specific cancer types because few cancer-associated antigens are known to induce tumor rejection. Accordingly, we assessed the utility of Ad881, an oncolytic adenovirus in which viral replication was strictly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c7939fe2ee8ae572a4de834e4fc55a
https://pubmed.ncbi.nlm.nih.gov/28035331
https://pubmed.ncbi.nlm.nih.gov/28035331
Publikováno v:
Molecular Therapy. 24:S85
Anti-angiogenic gene therapy represents a promising strategy for cancer; however, it has rarely been tested in malignant mesothelioma, a highly aggressive tumor associated with asbestos that has poor prognosis. In this study, we investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5479f7f3000d0e232f8a30764b9cf7b5
https://doi.org/10.1016/s1525-0016(16)33026-x
https://doi.org/10.1016/s1525-0016(16)33026-x